TP3 Global further strengthens its Healthcare Industry knowledge with the appointment of Doctor Michael Grillage to its Steering Committee.

Doctor Grillage has spent many years within Clinical Trials, Regulation and Product Launch environments.

Having studied medicine at Oxford, achieving an Honors Degree and an MA, Doctor Grillage focused on Phase 3 and 4 clinical trials and formed Ethical Medical Research Associates (EMRA) where the company undertook planning and regulation of Clinical Research Trials for a number of global Pharmaceutical and Healthcare companies.

Clive Wheeldon, TP3 Global Chief Executive Officer stated, “I am privileged to welcome Doctor Grillage to the TP3 Global Steering Committee. His wealth of experience and knowledge in the medical field makes for an excellent addition to the TP3 team”.

We look forward to working with Mike to provide even greater depth of service for our customers.”

About TP3 Global

Focusing on the passive protection of temperature sensitive cargo during transit, TP3 Global Ltd was founded in the UK and has manufacturing bases in the Americas, Europe and Asia. TP3 Global’s SilverSkin range of thermal pallet covers are qualified as GDP compliant and designed for protection of cold chain and controlled room temperature shipment protection world wide. TP3 Global works with the world’s largest Pharmaceutical, Healthcare and Perishable companies who have qualified SilverSkin insulated thermal pallet covers, blankets and quilts to support their cold chain, logistics and supply chain management needs.

Download as PDF